Société Compass Therapeutics, Inc. OTC Markets
Actions
CMPX
US20454B1044
Recherche biotechnologique et médicale
Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
3,55 USD | -10,80% | +32,67% | -.--% |
13/05 | Compass Therapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 | CI |
06/05 | Les plus fortes hausses du premarket | MT |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 53 | 01/01/17 | |
Thomas Schuetz
FOU | Founder | 63 | 01/01/14 |
Neil Lerner
DFI | Director of Finance/CFO | 56 | 01/01/20 |
Karin Herrera
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/23 |
Minori Rosales
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/05/23 |
General Counsel | - | 01/08/21 | |
Ian Chia
PRN | Corporate Officer/Principal | - | 01/01/18 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Richard Lindahl
BRD | Director/Board Member | 70 | 21/04/23 |
Mary Gray
BRD | Director/Board Member | 71 | 25/04/22 |
Ellen Chiniara
BRD | Director/Board Member | 65 | 25/04/22 |
Carl Gordon
CHM | Chairman | 59 | 01/01/15 |
Phil Ferneau
BRD | Director/Board Member | 62 | 01/01/15 |
Thomas Schuetz
FOU | Founder | 63 | 01/01/14 |
James Boylan
BRD | Director/Board Member | 57 | 01/11/22 |
Chief Executive Officer | 53 | 01/01/17 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 137 589 171 | 121 022 398 ( 87,96 %) | 0 | 87,96 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+8,29% | 114 Md | |
+10,21% | 104 Md | |
+0,44% | 22,28 Md | |
-11,90% | 22,41 Md | |
-4,64% | 19,07 Md | |
-37,36% | 18 Md | |
-5,17% | 17,89 Md | |
+7,70% | 14,28 Md | |
+37,65% | 12,55 Md |
- Bourse
- Actions
- Action CMPX
- Action CMPX
- Société Compass Therapeutics, Inc.